Vireo Growth (VREOF) Raw Materials (2020 - 2026)
Vireo Growth's (VREOF) quarterly Raw Materials came in at $11.3 million in Q1 2026, up 307.82% year-on-year from $2.8 million in Q1 2025, and up 20.21% quarter-over-quarter from $9.4 million in Q4 2025.
Vireo Growth (VREOF) Raw Materials (2020 - 2026) Analysis & Trends
Vireo Growth has disclosed Raw Materials across 7 years of filings, most recently posting $11.3 million for Q1 2026.
- Raw Materials for Q1 2026 came in at $11.3 million, up 307.82% year-over-year; the trailing twelve-month figure through Mar 2026 was $11.3 million (up 307.82% YoY), and the FY2025 annual result was $9.4 million, up 401.62% from the prior year.
- Raw Materials came in at $11.3 million for Q1 2026 at Vireo Growth, up from $9.4 million in the prior quarter.
- In the past five years, Raw Materials ranged from a high of $11.3 million in Q1 2026 to a low of $581193.0 in Q2 2023.
- The 5-year median for Raw Materials is $921450.0 (2024), against an average of $2.6 million.
- Across the five-year window, Raw Materials sank 30.17% in 2023 and surged 506.12% in 2025, its largest moves.
- Vireo Growth's Raw Materials stood at $791568.0 in 2022, then advanced by 19.91% to $949191.0 in 2023, then jumped by 97.42% to $1.9 million in 2024, then surged by 401.62% to $9.4 million in 2025, then rose by 20.21% to $11.3 million in 2026.
- The last three Raw Materials figures came in at $11.3 million (Q1 2026), $9.4 million (Q4 2025), and $5.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Vireo Growth | - | - | 59.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.30 Mn |
| Dec 31, 2025 | 9.40 Mn |
| Sep 30, 2025 | 5.59 Mn |
| Jun 30, 2025 | 5.19 Mn |
| Mar 31, 2025 | 2.77 Mn |
| Dec 31, 2024 | 1.87 Mn |
| Sep 30, 2024 | 921,450.00 |
| Jun 30, 2024 | 998,022.00 |
| Mar 31, 2024 | 884,060.00 |
| Dec 31, 2023 | 949,191.00 |
| Sep 30, 2023 | 805,031.00 |
| Jun 30, 2023 | 581,193.00 |
| Mar 31, 2023 | 685,809.00 |
| Dec 31, 2022 | 791,568.00 |
| Sep 30, 2022 | 662,474.00 |
| Jun 30, 2022 | 832,326.00 |
| Mar 31, 2022 | 791,376.00 |
| Dec 31, 2021 | 674,381.00 |
| Dec 31, 2020 | 346,493.00 |